TAKEDA PHARM.CO.LTD./ JP3463000004 /
2024-07-05 10:59:55 PM | Chg. +0.110 | Volume | Bid10:59:55 PM | Ask10:59:55 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
24.180EUR | +0.46% | - Turnover: - |
24.180Bid Size: - | 24.570Ask Size: - | 37.95 bill.EUR | - | - |
Fundamentals
FY 2024 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 92.09 JPY | -54.92% |
EPS Diluted: | - JPY | -54.86% |
Revenues per Share: | 2,717.48 JPY | 6.76% |
Book Value per Share: | 4,635.57 JPY | 15.43% |
Cash Flow per Share: | 456.56 JPY | -26.07% |
Dividend per Share: | 188.00 JPY | 4.44% |
Total | in mill. | |
Revenues: | 4,263,762.00 JPY | 5.87% |
Net Income: | 144,067.00 JPY | -54.56% |
Operating Cash Flow: | 716,344.00 JPY | - |
Cash and Cash Equivalents: | 457,800.00 JPY | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 46.07 | 45.43 |
P/S Ratio: | 1.56 | 1.54 |
P/BV ratio: | 0.92 | 0.90 |
P/CF Ratio: | 9.29 | 9.16 |
PEG: | -0.84 | -0.83 |
Earnings Yield: | 2.17% | 2.20% |
Dividend Yield: | 4.43% | 4.49% |
Market Capitalization | ||
Market Capitalization: | 37.95 bill. EUR | 37.42 bill. EUR |
Free Float Market Cap.: | - EUR | - EUR |
Market Cap. / Employee: | - EUR | - EUR |
Shares Outstanding: | 1.57 bill. |
Profitability
Gross Profit Margin: | 66.54% |
EBIT Margin: | 5.02% |
Net Profit Margin: | 3.38% |
Return on Equity: | 1.98% |
Return on Assets: | 0.95% |
Financial Strength
Liquidity I / Cash Ratio: | 19.79% |
Liquidity II / Quick Ratio: | 48.69% |
Liquidity III / Current Ratio: | 110.61% |
Debt / Equity Ratio: | 107.73% |
Dynam. Debt / Equity Ratio: | 1,093.82% |
Efficiency
Employees: | - |
Personal Expenses / Employee: | - JPY |
Revenues / Employee: | - JPY |
Net Income / Employee: | - JPY |
Total Assets / Employee: | - JPY |
* Fiscal Year End: | 2024-03-31 |
Accounting Standard: | IFRS |
Currency: | JPY |